Further analysis revealed that the tumor burden in the PbS/CdS-PEG-Epep + Laser group was reduced by 85.4% and 72.6% compared to the control group and the Nab-paclitaxel group, respectively, highlighting the highly significant anti-tumor effects of PbS/CdS-PEG-Epep + Laser in mammary duct ablation for early TNBC.
← all excerpts
Intraductal photothermal ablation: a noninvasive approach for early breast cancer treatment and prevention.
1
—
—